参考文献


  1. Petrucelli N, Daly MB, Feldman GL. BRCA1 and BRCA2 Hereditary Breast and Ovarian Cancer. 1998 Sep 4 [Updated 2013 Sep 26]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2015. Available from: NCBI
  2. American Association of Cancer Research. U.S. Breast Cancer Cases Expected to Increase by as Much as 50 Percent by 2030. April 20, 2015. AACR
  3. National Cancer Institute. BRCA1 & BRCA2: Cancer Risk & Genetic Testing. 2015. NCI
  4. Easton DF. How many more breast cancer predisposition genes are there? Breast Cancer Research. 1999;1(1):14-17. doi:10.1186/bcr6. NCBI
  5. American Cancer Society. Breast cancer risk factors you cannot change. 2015. ACS
  6. Sandhaus, Linda M., Mendel E. Singer, Neal V. Dawson, and Georgia L. Wiesner. Reporting BRCA Test Results to Primary Care Physicians. Gen in Med. 2001;3(5),327–34 NCBI
  7. Gabai-Kapara, Efrat, Amnon Lahad, Bella Kaufman, Eitan Friedman, Shlomo Segev, Paul Renbaum, Rachel Beeri, et al. Population-Based Screening for Breast and Ovarian Cancer Risk due to BRCA1 and BRCA2. Proc Natl Acad Sci USA. 2014;111(39),14205-14210 PNAS
  8. National Cancer Institute. A Snapshot of Ovarian Cancer. NCI. 2015. Retrieved 19 May 2015, from NCI
  9. Tuya Pal M.D., Jenny Permuth-Wey M.S., Judith A. Betts R.N., Jeffrey P. Krischer Ph.D., James Fiorica M.D., Hector Arango M.D., James LaPolla M.D., Mitchell Hoffman M.D., Martin A. Martino M.D., Katie Wakeley M.D., et al. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. ACS. 2005;104(12),2807-2816 Cancer
  10. King M-C, Levy-Lahad E, Lahad A. Population-Based Screening for BRCA1 and BRCA2. JAMA. 2014;312,(11):1091-1092 NCBI
  11. Maurano MT, et al. Systematic localization of common disease-associated variation in regulatory DNA. Science. 2012 Sep 7;337 (6099):1190-5. doi: 10.1126/science.1222794. Epub 2012 Sep 5. PMID: 22955828. SCIENCE
  1. American Cancer Society. Family Cancer Syndromes. 2016 ACS
  2. Green, R. C. et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. ACMG policy statement, Genetics in Medicine. July 2013. Volume 15, Number 7. GIM
  3. National Center for Chronic Disease Prevention and Health Promotion, Division for Heart Disease and Stroke Prevention. Heart Disease Facts. August 10, 2015.CDC
  4. Desmond A, et al., “Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment”, JAMA Oncol, 2015; 1(7):943-951. doi:10.1001/jamaoncol.2015.2690 JAMA
  5. Bhatt S, Parsa S, Snyder H, Taneja P, Halks-Miller M, Seltzer W, DeFeo E. Clinical Laboratory Experience with Noninvasive Prenatal Testing: Update on Clinically Relevant Metrics. ISPD 2014 poster.
  6. Illumina. Analytical Validation of the verifi prenatal test: Enhanced Test Performance for Detecting Trisomies 21, 18, and 13 and the Option for Classification of Sex Chromosome Status. Illumina White Paper. 2012.
  7. Gardner RJM, Sutherland GR, Shaffer LG. Parental age counseling and screening for fetal trisomy. Chromosome abnormalities and genetic counseling. 4 ed: Oxford University Press; 2012:403-416.
  8. Bianchi DW, Parker RL, Wentworth J, et al. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med. 2014;370(9):799-808.
  9. Nicolaides KH. Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn. 2011;31(1):7-15.
  10. The American Congress of Obstetricians and Gynecologists. NIPT Cell Free DNA Screening Predictive Value Calculator. National Society of Genetic Counselors (NSGC) and Perinatal Quality Foundation (PQF). Endorsed December 2015. 2015; http://www.acog.org/Resources-And-Publications/Endorsed-Documents. Accessed January 28, 2015.
  11. Committee Opinion No. 640: Cell-free DNA Screening for Fetal Aneuploidy. Obstet Gynecol. 2015;126(3):e31-37.
  12. Verinata Health, Inc. (2012) Accurate Aneuploidy Detection in Twin Pregnancies with an Optimized Algorithm for the verifi Prenatal Test. Redwood City, CA

HubSpot Tracking Code